Report updated Apr 18, 2026
Imprivata ID
For medical professionals and healthcare providers requiring secure, multi-factor authentication for clinical systems.
Overview · Full Intel report in progress
Imprivata ID is an established medical app that is completely free. With a 3.0/5 rating from 527 reviews, it shows polarized user reception.
What is Imprivata ID?
Current Momentum
v2026.1 · 5d ago
IntenseLast updated 5d ago. 5 versions tracked.
Competition
Rivals identification in progress
7-Day Rank Pulse 🇺🇸
MedicalRating Pulse 🇺🇸
What makes this app unique?
What Does It Look Like?
What Are The Key Features?
Enables wireless retrieval and verification of one-time passwords for EPCS without requiring manual code entry.
Provides identity verification for remote network access via lock-screen swipes on mobile devices.
Supports two-factor authentication requirements specifically for the electronic prescribing of controlled substances.
How much does it cost?
Who Built It?
Streamlining clinical workflows through secure, mobile-based identity verification. Enabling healthcare professionals to access systems with passwordless authentication.
Portfolio
1
Apps
Explore the full Imprivata report
Portfolio breakdown, audience, momentum, and every app published by Imprivata.
Analysis in progress, available soon
What do users think recently?
Analysis in progress, available soon
View the full user-sentiment analysis
Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.
Analysis in progress, available soon
What is the competitive landscape for Imprivata ID?
Where is it available?
Localized markets (1)
How's The Medical Market?
How does it evolve in the Medical market?
Rank progression
6 active rankings tracked — 30-day window
Strategic analysis coming soon
SWOT, key takeaways & outlook
The outtake for Imprivata ID
Key Takeaways
While the app is marketed as a high-speed clinical workflow tool, user feedback indicates significant inconsistency in synchronization and reliability.
Where Is It Heading?
Trend analysis
Available very soon